2026 Regular Session
HB417
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
1 roll call are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
March 4, 2026 · House
Third Reading Passed
Passed ⭐ Substantive final action
127 yea–0 nay · 5 not voting · 9 absent
Committee referrals
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
Senate Motion Special Order until Next Session (Senator Love) Adopted
-
Senate Favorable
-
Senate Favorable Report by Finance
-
Senate Referred Finance
-
House Third Reading Passed (127-0) View roll call
-
House Second Reading Passed with Amendments
-
House Favorable with Amendments {953328/1 Adopted
-
House Favorable with Amendments Report by Health
-
House Hearing 2/10 at 2:30 p.m.
-
House Hearing canceled
-
House Hearing 2/10 at 2:00 p.m.
-
House First Reading Health